Critical Care Pharmacy Specialty Review Course for Recertification, Core Therapeutic Modules + RECERT EXAMS Package (Cert # L229264)

The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.  

Board certified pharmacists are eligible to receive up to 19 contact hours of recertification credit for completing this course. To earn recertification credit, learners must review the course content and successfully complete the online assessments by the deadline. Only completed assessments will be eligible for credit; no partial or incomplete assessments will be processed.  You are allowed only one attempt to successfully complete this assessment.

This course is not intended for those preparing to take the BPS Critical Care Pharmacy Specialty Examination for Certification. To prepare for the examination, please see courses here: http://elearning.ashp.org/catalog/Crit-care-review 

These activities are part of the ASHP professional development program for BCCCP recertification approved by the BPS. 

* Please note: Review Course for Recertification may only be completed for recertification credit up to two times, in nonconsecutive years, during the 7-year recertification cycle.

After participating in this CPE activity, learners should be able to: 

Complex Case: Complications after Cardiac Surgery - Glucose, Sedation, and Thrombocytopenia
ACPE #: 0204-0000-22-633-H01-P

• Develop treatment and monitoring plans for a complex post-cardiac surgery patient to include pain, agitation and delirium, glucose management, and heparin-induced thrombocytopenia.
• Evaluate the impact of critical illness on pre-existing conditions (e.g., endocrine disorders, pain).
• Summarize quality assurance and process improvement methods relevant to critical care.
• Assess the relationship between institutional guideline development and evidence-based critical care literature. 

Complex Case: Acute Coronary Syndrome
ACPE #: 0204-0000-22-634-H01-P

• Develop treatment and monitoring plans for a complex critical care patient with acute coronary syndrome.
• Modify treatment and monitoring plans related to alterations of pharmacodynamics and pharmacokinetics in the critically ill.
• Select devices required for treatment and monitoring of a critical care patient.
• Select fluid, electrolyte and acid/base management and monitoring based on patient-specific factors. 

Complex Case: Antithrombotic-Associated Intracerebral Hemorrhage
ACPE #: 0204-0000-22-635-H01-P

• Develop treatment and monitoring plans for a complex critical care patient with antithrombotic-associated intracerebral hemorrhage (ICH).
• Select appropriate neurologic monitoring techniques.
• Recommend agents for acute volume resuscitation and hemostasis (e.g., blood products, hemostatic agents).
• Evaluate the impact of critical illness on preexisting conditions (e.g., cardiovascular diseases).
• Recommend fluid and electrolyte management based on patient-specific factors. 

Complex Case: Sepsis
ACPE #: 0204-0000-22-636-H01-P

• Develop treatment and monitoring plans for a complex critical care patient with an intra-abdominal infection, sepsis/SIRS, and shock.
• Select appropriate routes of administration for medications in critically ill patients.
• Modify treatment and monitoring plans related to alterations of pharmacodynamics and pharmacokinetics in the critically ill.
• Recommend agents for acute volume resuscitation and hemostasis (e.g., crystalloids, colloids). 

Complex Case: Hyperglycemic Emergency and Community-Acquired Pneumonia
ACPE #: 0204-0000-22-637-H01-P

• Develop treatment and monitoring plans for a complex critical care patient with hyperglycemic emergency and community-acquired pneumonia.
• Select appropriate routes and methods of administration for medications in critically ill patients.
• Select fluid, electrolyte and acid/base management and monitoring based on patient-specific factors.
• Choose agents for acute volume resuscitation.
• Identify medication safety issues patients requiring care in the ICU.
• Explain nutrition support in the critically ill patient. 

Complex Case: Pneumonia
ACPE #: 0204-0000-22-638-H01-P

• Develop treatment and monitoring plans for a complex critical care patient with multiple conditions, including pneumonia and acute respiratory distress syndrome (ARDS).
• Identify drug interactions and adverse drug events common in critical care and methods to document. 

Complex Case: Oncologic Emergencies: Febrile Neutropenia, Tumor Lysis Syndrome, and Hypercalcemia of Malignancy
ACPE #: 0204-0000-22-639-H01-P

• Develop treatment and monitoring plans for a complex critical care patient with febrile neutropenia, tumor lysis syndrome, or hypercalcemia of malignancy.
• Select fluid, electrolyte and acid/base management and monitoring based on patient-specific factors.
• Evaluate the impact of critical illness on pre-existing conditions (e.g., cancer). 

Complex Case: GI Bleeding and Acute Kidney Failure
ACPE #: 0204-0000-22-640-H01-P

• Develop treatment and monitoring plans for a complex critical care patient with gastrointestinal bleeding, alcohol withdrawal, refeeding syndrome, hepatorenal syndrome, cirrhosis, and acute kidney failure with kidney replacement therapy.
• Modify treatment and monitoring plans related to alterations of pharmacodynamics and pharmacokinetics in the critically ill.
• Select appropriate routes of administration for medications in critically ill patients.
• Recommend agents for acute volume resuscitation and hemostasis (e.g., blood products, hemostatic agents). 

Statistics, Evidence-Based Medicine, and Clinical Trial Design
ACPE #: 0204-0000-21-985-H04-P

• Determine quality and appropriateness of a study by examining study design, statistical analysis, sources of bias, quality of conclusions, and interpretation of graphs.
• Determine clinical and statistical significance of a study outcome.
• Determine whether the study applies to a specified patient population. 

Practice Administration and Development Part 1
ACPE #: 0204-0000-22-641-H04-P

• Develop a plan to monitor and evaluate compliance with, and impact of, policies and guidelines (e.g., institutional, evidence based).
• Describe the application and integration of evidence-based critical care literature into institutional guidelines and processes.
• Evaluate regulatory/IRB requirements relative to conducting critical care research.
• Select quality assurance methods and improvement activities, including needs assessment techniques, aimed at enhancing the safety and effectiveness of medication-use processes in the critical care area. 

Practice Administration and Development Part 2
ACPE #: 0204-0000-22-642-H04-P

• Identify metrics for evaluating the quality of critical care pharmacy services (e.g., lengths of ICU stay, mortality, cost-effectiveness, ROI).
• Summarize the evidence-based literature that supports the value of critical care pharmacy.
• Summarize the factors that enhance the education and training of critical care pharmacists available in published documents from relevant professional societies (e.g., ASHP, ACCP, SCCM).

The Core Therapeutic Modules for Recertification Package consists of 3 activities (see table below). In each activity, faculty review clinical topics and practice skills using a case-based approach. This package is intended for board certified pharmacists in need of recertification credit; the activities were designed based on the content outline developed by the Board of Pharmacy Specialties (BPS).

After participating in these CPE activities, learners should be able to:

Select Topics in Infectious Diseases in Critical Care Patients
ACPE #: 0204-0000-22-643-H01-P

For the following specific infectious disease topics: urinary tract infections, meningitis, catheter related infections, bacteremia, and infective endocarditis:

• Interpret laboratory and diagnostic tests.
• Recommend the most appropriate treatment and monitoring plans based on patient-specific information and current guidelines. 

Select Topics in Pulmonary Disorders
ACPE #: 0204-0000-22-644-H01-P

For the following specific pulmonary disease topics: asthma exacerbation, acute exacerbation of chronic obstructive pulmonary disease, pulmonary embolism, and pulmonary arterial hypertension:

• Interpret laboratory and diagnostic tests.
• Recommend the most appropriate treatment and monitoring plans based on patient-specific information and current guidelines. 

Fluid, Electrolytes, and Nutrition
ACPE #: 0204-0000-22-617-H01-P

• Interpret laboratory and diagnostic tests for fluid, electrolyte, and nutrition status.
• Recommend the most appropriate therapy and monitoring in patients with fluid, electrolyte, and nutritional disorders based on patient-specific information and current guidelines.
• Apply strategies to manage drug-related electrolyte interactions and nutrient interactions.

Faculty Bios

Angela L. Bingham, PharmD, BCPS, BCNSP, BCCCP, FASPEN, FCCP, FASHP*
Vice Chair and Associate Professor of Clinical Pharmacy
Philadelphia College of Pharmacy
Philadelphia, Pennsylvania 

Quinn Czosnowski, PharmD, BCCCP
Clinical Pharmacy Specialist, Critical Care
Indiana University Health - Methodist Hospital
Indianapolis, Indiana 

Brian Dee, PharmD, BCCCP, BCNSP, FCCM
Clinical Pharmacy Specialist - Critical Care/Nutrition Support
The University of Texas MD Anderson Cancer Center
Houston, Texas 

J. Tyler Haller, PharmD, BCCCP
Clinical Pharmacy Specialist- Neurocritical Care
St. Josephs Hospital and Medical Center
Phoenix, Arizona 

Mary M. Hess, PharmD, BSPharm, BCCCP, FASHP, FCCM, FCCP*
Associate Dean
Professor, Pharmacy Practice
Jefferson College of Pharmacy
Philadelphia, Pennsylvania 

Lauren A. Igneri, PharmD, BCPS, BCCCP
Critical Care Clinical Pharmacy Specialist
Cooper University Healthcare
Camden, New Jersey 

Patricia Kienle, MPA, BCSCP, FASHP
Director, Accreditation and Medication Safety
Cardinal Health
Wilkes-Barre, Pennsylvania

John Marshall, PharmD, BCPS, BCCCP, FCCM
Director, Clinical Pharmacy Programs
Massachusetts General Hospital
Boston, Massachusetts 

Diana Solomon, PharmD, BCCCP
Critical Care Clinical Pharmacy Specialist
Cooper University HealthCare
Camden, New Jersey 

Jill Starykowicz, PharmD, BCCCP
Clinical Pharmacy Specialist, Cardiology/Medical Intensive Care
Advocate Lutheran General Hospital
Park Ridge, Illinois 

Rachel Swope, PharmD, BCCCP
Clinical Pharmacy Manager
Norton Healthcare
Louisville, Kentucky 

Paul Szumita, PharmD, FCCM, FASHP, BCCCP, BCPS*
Director, Clinical Pharmacy Services
Boston, Massachusetts 

Heather Torbic, PharmD, BCPS, BCCCP
Medical ICU Clinical Pharmacy Specialist, Critical Care PGY2 Program Director
Cleveland Clinic
Cleveland, Ohio

*Content Matter Experts

Amber Adams, PharmD, BCPS, BCCCP
Shannon Allcron, PharmD, BCCCP, BCPS
Edward Alvarez, PharmD, BCIDP, BCCCP
John Austin, PharmD, BCPS, BCCCP
Eugene Bush, PhD, BCPS, BCCCP
Genevieve Cheung, PharmD, BCCCP
Andrew DeSio, PharmD, BCPS, BCCP, BCCCP, BCIDP
Sonia Everhart, PharmD, BCPS, BCCCP, FCCM
Shinelle Green, PharmD, BCCCP
Gloria Gutierrez, PharmD, BCCCP
Coleen Hart, Pharm.D., BCPS, BCCCP
Lawahidh Hasham, PharmD, BCPS
Jessica Hasty, PharmD, BCCCP
William Heuser, PharmD, MS, BCCCP
Rebecca Hilton, PharmD, BCCCP
Jeremy Hodges, PharmD, BCPS, BCCCP, CPP
Miranda Howland, PharmD, BCCCP
John Johnson, BPharm, BCCCP, BCPS, BCNSP
Maureen Jones, PharmD, BCCCP
Kirstin Kooda, PharmD, BCPS, BCCCP
Laura Koons, PharmD, MSP, BCCCP
Janell Krack, PharmD, BCPS, BCCCP
Jacky  Lee, PharmD, BCPS, BCCCP
Bryan Levano, BS, MS, RPh, BCCCP
Thomas Maggio, PharmD, BCCCP
Emily Miller, PharmD, FCCM, BCCCP
Oussayma Moukhachen, PharmD, BCPS, BCCCP
Talal Nassar, PharmD, BCCCP, MS
Christopher Nixon, PharmD, BCCCP
Amber Ooley, PharmD, BCPS, BCCCP
Cathlena  Paul , RPh, BCCCPS
Abbey Pitzenberger, PharmD, BCPS, BCCCP
Derek Polly, PharmD, BCCCP
Denise Pratt, PharmD, BCCCP
Joshua Schrader, PharmD, BCCCP
Michael Semanco, PharmD, BCPS, BCCCP
Ryan Servais, PharmD, BCPS, BCCCP, BCCP
Myroslava Sharabun, PharmD, BCPS, BCCCP
Bridger Singer, PharmD, BCPS, BCCCP
Mary Lynn Skruck , PharmD, BCPS, BCCCP
Katherine Spezzano, PharmD, MBA, BCCCP
Caroline Taazieh , PharmD, BCPS, BCCCP, BCIDP, BCCP
Terri Tieman, PharmD, BCPS, BCCCP
Emily J. Tschumper, PharmD, MS, BCPS, BCCCP
Jessica Ward, PharmD, BCCCP
Kathryn Wierer, PharmD, BCCCP, BCPPS

In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support and the Accreditation Council for Pharmacy Education’s Standards for Commercial Support, ASHP requires that all individuals involved in the development of activity content disclose their relevant financial relationships. A person has a relevant financial relationship if the individual of his or her spouse/partner has a financial relationship (e.g. employee, consultant, research grant recipient, speakers bureau, or stockholder) in any amount occurring the in the last 12 months with a commercial interest whose products or series may be discussed in the educational activity content over which the individual has control. The existence of these relationships is provided for the information of participants and should not be assumed to have an adverse impact on the content.

All faculty and planners for ASHP education activities are qualified and selected by ASHP and required to disclose any relevant financial relationships with commercial interests. ASHP identifies and resolves conflicts of interest prior to an individual’s participation in development of content for an educational activity. Anyone who refuses to disclose relevant financial relationships must be disqualified from any involvement with a continuing pharmacy education activity.

All other planners, presenters, and reviewers of this session report no financial relationships relevant to this activity.

Activities can be completed in any order. Each activity consists of audio, video, and/or PDFs and evaluations. Learners must review all content and complete the evaluations to receive continuing pharmacy education credit for each activity. 

Follow the prompts to claim, view, or print the statement of credit within 60 days after completing the activity. 

These activities were developed by ASHP.